A phase II trial of paclitaxel in refractory germ cell tumors.
about
Current status and future perspectives in the treatment of advanced testicular cancer.Recent advances in management of patients with platinum-refractory testicular germ cell tumors.A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors.Irinotecan plus cisplatin has substantial antitumor effect as salvage chemotherapy against germ cell tumors.Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group.
P2860
A phase II trial of paclitaxel in refractory germ cell tumors.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
A phase II trial of paclitaxel in refractory germ cell tumors.
@en
type
label
A phase II trial of paclitaxel in refractory germ cell tumors.
@en
prefLabel
A phase II trial of paclitaxel in refractory germ cell tumors.
@en
P2093
P2860
P1433
P1476
A phase II trial of paclitaxel in refractory germ cell tumors.
@en
P2093
Nichols CR
Sandler AB
Williams SD
P2860
P304
P356
10.1002/(SICI)1097-0142(19980401)82:7<1381::AID-CNCR23>3.0.CO;2-1
P407
P577
1998-04-01T00:00:00Z